Key Takeaway: The article mentions the ASPEN 2025 Nutrition Science & Practice Conference but provides no specific details about the event. It primarily discusses cookie usage for user experience and marketing purposes on the website.
Market Sentiment Analysis
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Cash runway
~0 mo
High dilution risk
Lead asset
NG Shield
Phase 2 · Intubation, Nasogastric
Full Press Release Details
We use cookies primarily to improve your user experience and for marketing purposes. By using this site you agree to our use of cookies. For more information, please read our